Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001400253-26-000044

Chief Executive Officer disposed of 5,102 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Virnich Daniel · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-17 Other disposition : show line 1 in the form −5,102 $3.40 $17,347 2,332,064 D
Loading xslF345X06/ownership.xml…